Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Kiora Pharmaceuticals (KPRX) Return on Equity (2016 - 2025)

Kiora Pharmaceuticals' Return on Equity history spans 11 years, with the latest figure at 0.56% for Q4 2025.

  • For Q4 2025, Return on Equity fell 69.0% year-over-year to 0.56%; the TTM value through Dec 2025 reached 0.56%, down 69.0%, while the annual FY2025 figure was 0.52%, 74.0% down from the prior year.
  • Return on Equity reached 0.56% in Q4 2025 per KPRX's latest filing, down from 0.38% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.18% in Q3 2024 to a low of 2.66% in Q4 2021.
  • Average Return on Equity over 5 years is 0.91%, with a median of 0.56% recorded in 2025.
  • Peak YoY movement for Return on Equity: tumbled -199bps in 2022, then soared 188bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 2.66% in 2021, then grew by 6bps to 2.5% in 2022, then rose by 30bps to 1.75% in 2023, then surged by 107bps to 0.13% in 2024, then plummeted by -536bps to 0.56% in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Return on Equity are 0.56% (Q4 2025), 0.38% (Q3 2025), and 0.52% (Q2 2025).